Desmons P - Search Results

1

Activation of monocytes by three OspA vaccine candidates: lipoprotein OspA is a potent stimulator of monokines.

Häupl T, Landgraf S, Netusil P, Biller N, Capiau C, Desmons P, Hauser P, Burmester GR. Häupl T, et al. Among authors: desmons p. FEMS Immunol Med Microbiol. 1997 Sep;19(1):15-23. doi: 10.1111/j.1574-695X.1997.tb01068.x. FEMS Immunol Med Microbiol. 1997. PMID: 9322065 Free article.

2

Reactivity with a specific epitope of outer surface protein A predicts protection from infection with the Lyme disease spirochete, Borrelia burgdorferi.

Golde WT, Piesman J, Dolan MC, Kramer M, Hauser P, Lobet Y, Capiau C, Desmons P, Voet P, Dearwester D, Frantz JC. Golde WT, et al. Among authors: desmons p. Infect Immun. 1997 Mar;65(3):882-9. doi: 10.1128/IAI.65.3.882-889.1997. Infect Immun. 1997. PMID: 9038292 Free PMC article.

3

The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey.

Philipp MT, Lobet Y, Bohm RP Jr, Roberts ED, Dennis VA, Gu Y, Lowrie RC Jr, Desmons P, Duray PH, England JD, Hauser P, Piesman J, Xu K. Philipp MT, et al. Among authors: desmons p. Vaccine. 1997 Dec;15(17-18):1872-87. doi: 10.1016/s0264-410x(97)00133-3. Vaccine. 1997. PMID: 9413097

4

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults.

Van Hoecke C, Comberbach M, De Grave D, Desmons P, Fu D, Hauser P, Lebacq E, Lobet Y, Voet P. Van Hoecke C, et al. Among authors: desmons p. Vaccine. 1996 Dec;14(17-18):1620-6. doi: 10.1016/s0264-410x(96)00146-6. Vaccine. 1996. PMID: 9032890 Clinical Trial.

5

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 1. Safety and immunogenicity in young, healthy adults.

Leroux-Roels G, Desombere I, De Tollenaere G, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Among authors: desmons p. Vaccine. 1997 Nov;15(16):1724-31. doi: 10.1016/s0264-410x(97)00117-5. Vaccine. 1997. PMID: 9364674 Clinical Trial.

6

Evaluation of protection conferred by several acellular pertussis vaccines in an intranasal model of B. pertussis infection.

Hauser P, Simoen E, Capiau C, Comberbach M, Desmons P, Veenstra S, Slaoui M. Hauser P, et al. Among authors: desmons p. Biologicals. 1999 Jun;27(2):163. doi: 10.1006/biol.1999.0202. Biologicals. 1999. PMID: 10600206 Review. No abstract available.

7

Hepatitis B vaccine containing surface antigen and selected preS1 and preS2 sequences. 2. Immunogenicity in poor responders to hepatitis B vaccines.

Leroux-Roels G, Desombere I, Cobbaut L, Petit MA, Desmons P, Hauser P, Delem A, De Grave D, Safary A. Leroux-Roels G, et al. Among authors: desmons p. Vaccine. 1997 Nov;15(16):1732-6. doi: 10.1016/s0264-410x(97)00118-7. Vaccine. 1997. PMID: 9364675 Clinical Trial.

8

Primary vaccination of infants with a combined diphtheria-tetanus-acellular pertussis-hepatitis B vaccine.

Kanra G, Ceyhan M, Ecevit Z, Bogaerts H, De Grave D, Hauser P, Desmons P. Kanra G, et al. Among authors: desmons p. Pediatr Infect Dis J. 1995 Nov;14(11):998-1000. doi: 10.1097/00006454-199511000-00014. Pediatr Infect Dis J. 1995. PMID: 8584369 Clinical Trial. No abstract available.

9

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.

Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garçon N, Krzych U, Marchand M. Stoute JA, et al. Among authors: desmons p. N Engl J Med. 1997 Jan 9;336(2):86-91. doi: 10.1056/NEJM199701093360202. N Engl J Med. 1997. PMID: 8988885 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters